Prostate Cancer Clinical Trials in Georgia

Showing 121-140 of 165 trials

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

NCT02047253

This study will test how effective the drug, Carfilzomib, reduces progression of prostate cancer in patients who have previously received chemotherapy and androgen inhibitors. Carfilzomib is approved for multiple myeloma but is not approved for prostate cancer. Therefore, it is considered investigational. Other approved methods of treatment for metastatic prostate cancer have demonstrated only modest benefits. Novel and tolerable agents are necessary to make further gains and extend overall survival.

Metastatic Castration-resistant Prostate Cancer

University of Alabama at Birmingham28 participantsStarted Apr 2014

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Macon, Georgia, United States +1 more locations

COMPLETEDPHASE3154 miles

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

NCT00988208

The purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with metastatic Castrate-Resistant Prostate Cancer. The addition of lenalidomide to docetaxel and prednisone is proposed to increase the life expectancy of these subjects.

Prostate Cancer

Celgene1,059 participantsStarted Nov 2009

Phoenix, Arizona, United States • Sedona, Arizona, United States • Tucson, Arizona, United States +207 more locations

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Prostate Cancer Trials in Other Cities

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Vidaza to Restore Hormone Thx Prostate

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

An Open-label Extension Study of PSMA ADC 2301 in mCRPC

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

CHESS: Human and Computer Mentors for Prostate Cancer Patients

Health-Related Quality of Life in Gay Men With Localized Prostate Cancer

Other Conditions in Georgia